Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Depressions following reserpine: a reevaluation.

× No keyword cloud information.

18 in total

1. A new method for rapidly and simultaneously decreasing serotonin and catecholamine synthesis in humans.

Authors: Marco Leyton; Valerie Kwai Pun; Chawki Benkelfat; Simon N Young
Journal: J Psychiatry Neurosci Date: 2003-11 Impact factor: 6.186

Review 2. Tobacco addiction and the dysregulation of brain stress systems.

Authors: Adrie W Bruijnzeel
Journal: Neurosci Biobehav Rev Date: 2012-03-03 Impact factor: 8.989

Review 3. Drugs and depression.

Authors: F A Whitlock; L E Evans
Journal: Drugs Date: 1978-01 Impact factor: 9.546

4. Sleep disturbances, nightmares and other possible central nervous disturbances in a population sample of women, with special reference to those on antihypertensive drugs.

Authors: C Bengtsson; J Lennartsson; O Lindquist; H Noppa; J Sigurdsson
Journal: Eur J Clin Pharmacol Date: 1980 Impact factor: 2.953

5. Drug-associated psychiatric disturbances in medical inpatients.

Authors: D A Danielson; J B Porter; D H Lawson; C Soubrié; H Jick
Journal: Psychopharmacology (Berl) Date: 1981 Impact factor: 4.530

6. Brain alpha(2)-adrenoceptors in monoamine-depleted rats: increased receptor density, G coupling proteins, receptor turnover and receptor mRNA.

Authors: C Ribas; A Miralles; X Busquets; J A García-Sevilla
Journal: Br J Pharmacol Date: 2001-04 Impact factor: 8.739

7. Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects.

Authors: Gregor Hasler; Stephen Fromm; Paul J Carlson; David A Luckenbaugh; Tracy Waldeck; Marilla Geraci; Jonathan P Roiser; Alexander Neumeister; Noah Meyers; Dennis S Charney; Wayne C Drevets
Journal: Arch Gen Psychiatry Date: 2008-05

Review 8. Vilazodone: a 5-HT1A receptor agonist/serotonin transporter inhibitor for the treatment of affective disorders.

Authors: Lee A Dawson; Jeannette M Watson
Journal: CNS Neurosci Ther Date: 2009 Impact factor: 5.243

Review 9. Innovative approaches for the development of antidepressant drugs: current and future strategies.

Authors: Lee E Schechter; Robert H Ring; Chad E Beyer; Zoë A Hughes; Xavier Khawaja; Jessica E Malberg; Sharon Rosenzweig-Lipson
Journal: NeuroRx Date: 2005-10

Review 10. Drug-induced depression in the aged. What can be done?

Authors: L Ganzini; J R Walsh; S B Millar
Journal: Drugs Aging Date: 1993 Mar-Apr Impact factor: 3.923